Concepedia

Yoko Amada

YA

4

Publications

97

Citations

4

H-Index

2003

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Yoko Amada is an author at Astellas Pharma (Japan) specializing in neuropharmacology, neurophysiology, and synaptic transmission.

Top concepts

Publications per year

2003–2013

4

Publications

4

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4 H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

Hiroshi Yamashita, K Ohno, Yoko Amada et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 32 citations

Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects: Results from Single- and Multiple-Dose Studies

Hiromi Iitsuka, Tomoaki Tokuno, Yoko Amada et al. · Clinical Drug Investigation · 2013 · 30 citations · Full text

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

K Ohno, Rie Tsutsumi, Naoyuki Matsumoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 25 citations

Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats

Hiroshi Yamashita, K Ohno, Yoko Amada et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 10 citations

, , +12

Rows per page

1–4 of 4